VPS4A: A Potential Drug Target and Biomarker for Vacuolar Protein Sorting-Associated Protein 4A

Target Name: VPS4A

NCBI ID: G27183

VPS4A

VPS4A: A Potential Drug Target and Biomarker for Vacuolar Protein Sorting-Associated Protein 4A

Abstract:

Vacuolar protein sorting-associated protein 4A (VPS4A) is a protein that plays a crucial role in the regulation of intracellular protein transport, specifically in the vacuole, where it helps to ensure the proper sorting of proteins for various cellular processes. The identification of VPS4A as a potential drug target and biomarker has significant implications for the development of new therapeutic strategies for various diseases.

Introduction:

Vacuolar protein sorting-associated protein 4A (VPS4A) is a member of the VPS4A gene family, which is known to be involved in various cellular processes, including the regulation of protein transport and localization in the cytosol and endoplasmic reticulum (ER). VPS4A is primarily localized to the endoplasmic reticulum (ER), where it is involved in the sorting of proteins for import into the ER, and subsequent transport to the cytosol for further processing or degradation.

The Role of VPS4A in Protein Sorting:

VPS4A is a key protein in the ER-to-cytosol transport system, where it helps to regulate the import of proteins into the cytosol. This is critical for various cellular processes, including the delivery of proteins involved in cell signaling pathways, such as tyrosine kinases and ion channels. In addition, VPS4A is involved in the export of proteins involved in stress responses, such as heat shock proteins (HSPs) and proton channels.

The unique feature of VPS4A is its ability to import proteins while also exporting them, which allows it to act as a chaperone for protein transport. This function is critical for ensuring that properly sorted proteins reach their destination in the cytosol and are either processed or degraded.

VPS4A is also involved in the regulation of protein stability and localization in the ER. This is important for ensuring that properly sorted proteins are retained in the ER and are not released into the cytosol, where they may cause harm or be involved in misfolding and protein degradation.

Potential Drug Targets:

The identification of VPS4A as a potential drug target has significant implications for the development of new therapeutic strategies for various diseases. One of the main targets of VPS4A is the regulation of protein transport, which is critical for the delivery of proteins involved in cellular signaling pathways and stress responses.

In addition, VPS4A may also be a target for diseases associated with protein misfolding, such as neurodegenerative diseases and diseases associated with protein misfolding, such as cancer. By targeting VPS4A, researchers may be able to develop new therapeutic strategies for these diseases and improve current treatments.

Biomarkers:

The identification of VPS4A as a potential drug target also has significant implications for the development of new biomarkers for various diseases. One of the main applications of VPS4A is its involvement in the regulation of protein transport, which makes it a potential biomarker for diseases associated with protein misfolding, such as neurodegenerative diseases and cancer.

In addition, the regulation of protein transport by VPS4A may also be used as a biomarker for diseases associated with protein stability and localization in the ER, such as phenylketonuria (PKU). PKU is a genetic disorder that is characterized by the inability of children to break down certain proteins that can cause damage to the brain.

Conclusion:

Vacuolar protein sorting-associated protein 4A (VPS4A) is a protein that plays a crucial role in the regulation of intracellular protein transport, specifically in the vacuole, where it helps to ensure the proper sorting of proteins for various cellular processes. The identification of VPS4A as a potential drug target and biomarker has significant implications for

Protein Name: Vacuolar Protein Sorting 4 Homolog A

Functions: Involved in late steps of the endosomal multivesicular bodies (MVB) pathway. Recognizes membrane-associated ESCRT-III assemblies and catalyzes their disassembly, possibly in combination with membrane fission. Redistributes the ESCRT-III components to the cytoplasm for further rounds of MVB sorting. MVBs contain intraluminal vesicles (ILVs) that are generated by invagination and scission from the limiting membrane of the endosome and mostly are delivered to lysosomes enabling degradation of membrane proteins, such as stimulated growth factor receptors, lysosomal enzymes and lipids. It is required for proper accomplishment of various processes including the regulation of endosome size, primary cilium organization, mitotic spindle organization, chromosome segregation, and nuclear envelope sealing and spindle disassembly during anaphase (PubMed:33186545). Involved in cytokinesis: retained at the midbody by ZFYVE19/ANCHR and CHMP4C until abscission checkpoint signaling is terminated at late cytokinesis. It is then released following dephosphorylation of CHMP4C, leading to abscission (PubMed:24814515). VPS4A/B are required for the exosomal release of SDCBP, CD63 and syndecan (PubMed:22660413). Critical for normal erythroblast cytokinesis and correct erythropoiesis (PubMed:33186543)

The "VPS4A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VPS4A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets